Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-24 @ 10:55 PM
NCT ID: NCT01668069
Eligibility Criteria: Inclusion Criteria: * Women who are less than 16 weeks pregnant by last menstrual period or ultrasound * Greater than 18 years of age * English speaking * No significant visual or hearing impairment * Requesting treatment for nausea associated with pregnancy Exclusion Criteria: * If nausea or vomiting preexisted the pregnancy * Requires hospitalization at the time of initial enrollment * Already taking anti-emetics to include metoclopramide, ondansetron, doxylamine, pyridoxine, or promethazine * The patient has an allergy to either study regimen * If they are unable to return for a follow up visit in 1 week
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 90 Years
Study: NCT01668069
Study Brief:
Protocol Section: NCT01668069